Shared on 29 Oct 25
Narrative Update on Rubicon Organics Analysts have maintained their fair value price target for Rubicon Organics at $1.15. Recent reassessments indicate minimal changes to underlying growth and profitability assumptions.
Shared on 15 Oct 25
Fair value Decreased 12%Global Cannabis Acceptance And Facility Expansion Will Unlock Long-Term Opportunity
Analysts have revised their price target for Rubicon Organics downward by $0.15 to $1.15 per share, citing tempered revenue growth expectations. This adjustment comes despite a modest improvement in projected profit margins and a lower future price-to-earnings ratio.
Shared on 19 Aug 25
Fair value Increased 18%Global Cannabis Acceptance And Facility Expansion Will Unlock Long-Term Opportunity
Driven by notable improvements in both forecasted revenue growth (from 10.6% to 16.3% annually) and net profit margin (from 2.67% to 4.92%), Rubicon Organics' consensus analyst price target has been raised from CA$1.10 to CA$1.30. What's in the News Rubicon Organics launched its new 1964 Supply Co. All-in-One Full Spectrum Extract Resin Vapes in Canada, featuring premium resin and targeting legacy market consumers; two more AIO products are planned by year-end.